These observations were also reflected by SIGLEC10 mRNA expression levels among B cell subsets from healthy adults (n = 5 each) and tumor and normal residual B cells from 9 CLL patients, as determined by RNAseq (Fig 8B). This evidence concerns the gene SIGLEC10 and B-cell chronic lymphocytic leukemia.